Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin-Preliminary report

Int J Antimicrob Agents. 2013 Aug;42(2):190-1. doi: 10.1016/j.ijantimicag.2013.05.002. Epub 2013 Jun 21.

Authors

Jean-Paul Casalta, Caroline Zaratzian, Sandrine Hubert, Franck Thuny, Frédérique Gouriet, Gilbert Habib, Dominique Grisoli, Jean-Claude Deharo, Didier Raoult

PMID: 23796892
DOI: 10.1016/j.ijantimicag.2013.05.002

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Clindamycin / therapeutic use*
Endocarditis, Bacterial / drug therapy*
Humans
Prospective Studies
Retrospective Studies
Staphylococcal Infections / drug therapy*
Staphylococcus aureus / drug effects
Treatment Outcome
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

Anti-Bacterial Agents
Clindamycin
Trimethoprim, Sulfamethoxazole Drug Combination